|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4447 | Drugs / Medical | 09/30/2005
GlaxoSmithKline and the FDA notified healthcare professionals of changes to the pregnancy/precautions section of the prescribing information for Paxil and Paxil CR Controlled-Release Tablets. Glaxo's studies suggest Paxil may be more likely to be linked to birth defects than similar drugs.
The manufacturer of Paxil, GlaxoSmithKline Plc, is alerting physicians about the results of a study of major congenital malformations in infants born to women taking antidepressants during the first trimester of pregnancy. The company, in a letter posted on the Food and Drug Administration Web site, said it was adding the information to the prescribing instructions on Paxil's label. Glaxo added that most of the defects were cardiovascular in infants born to women who took the drug during the first trimester of pregnancy. "Preliminary results suggest an increase in the risk of congenital malformations associated with the use of Paxil as compared to other antidepressants," the company's letter to physicians said. "The preliminary results of this study and recent abstracts ... differ from previous epidemiologic studies, making it difficult to conclude whether a causal relationship exists," it said. The FDA states that physicians should "carefully weigh the potential risks and benefits of using paroxetine (Paxil) therapy in women during pregnancy and should discuss these findings as well as treatment alternatives with their patients." Legal Action Kahn Gauthier Swick is currently investigating claims relating to Paxil and Paxil CR use during pregnancy. If your baby suffered birth defects as a result of using Paxil during your pregnancy, our attorneys may be able to assist you. Register your Glaxosmithkline ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Glaxosmithkline, or click the red "submit" button on this page, and a lawyer will review your Glaxosmithkline complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest A class action has been filed against biopharmaceutical company CV Therapeutics, Inc. (Nasdaq: CVTX) and certain of its officers and directors by stockholders who purchased the company's common stock between May 14 and August 1, 2003.
A class action lawsuit has been filed in US District Court against Arkansas based Beverly Enterprises, Inc. d/b/a Beverly Healthcare The case involves violations of contract law. No additional information about the substance of the allegations is available at this time. Classactionamerica.com will monitor this case and provide additional details as soon as they become available. A New York City attorney filed a class action complaint in the Southern District of New York on March 6, 2006, against sanofi-aventis Group, the manufacturer of the widely prescribed sleep medication Ambien. Before filing the case, the attorney interviewed people nationwide and an expert pharmacologist. All confirmed the dangerous side effects of Ambien. Four class representatives relate their experiences in the Complaint of taking Ambien for good nights sleep and waking up only to find themselves in jail, driving cars while in a hypnotic state and binge eating at night where their spouses shoveled food from their mouths. The attorney explains, "The purpose of our lawsuit is to insure Ambien warns consumers and doctors about the adverse side effects of sleep walking and sleep eating because it is unfair to Ambien users to enter this hypnotic state then sleep walk and drive, putting themselves and others in danger. You don't want to be that other person crossing the road when an Ambien user is hypnotically driving towards you. The worst part of those side effects is that these people have absolutely no memory of what happened to them after they took Ambien." A class action has been filed against St. Joe Paper Company and its successor, The St. Joe Company, on behalf of the residents of Millview, a neighborhood in the panhandle town of Port St. Joe, Florida. The suit alleges that the companies knowingly exposed the plaintiffs to hazardous substances. A class action has been filed against Washington Hospital Center for failing to provide a reasonable volume of free or reduced priced medical care to poor, uninsured patients and from conditioning emergency treatment on a patient's payment or ability to pay agreement. The parties have reached a $35+ million USD settlement in three class actions filed against Dow Corning on behalf of Canadians who claim that silicone surgical implants have caused them health problems, in violation of Canadian consumer protection statutes. There are numerous claims deadlines that range from August 30, 2004, to June 3, 2019, depending on the type of claim that is being filed. Persons eligible to take part in the settlements should visit the settlement websites for more information. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
